Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 361 AL 375

Beyond target engagement: RNA therapeutics and the neuroimmune challenge in tauopathies

Breen EA.

J Prev Alzheimers Dis. 2026 Aug;13(7):100626. doi: 10.1016/j.tjpad.2026.100626. Epub 2026 Jun 15.

Next-generation intranasal delivery nano-platforms for targeted brain therapy of Alzheimer's disease

Malaiya A, Kenwat R, Mamgain A, Paliwal SR, Sulakhiya K, Maiti S, Paliwal R.

Nanomedicine (Lond). 2026 Jun;21(12):1775-1795. doi: 10.1080/17435889.2026.2685131. Epub 2026 Jun 16.

Role of suvorexant in Alzheimer's disease: Targeting sleep, orexin signaling, and disease pathophysiology

Ahmed Abbasi A, Norouziyan F, Moradikor N.

J Alzheimers Dis. 2026 Aug;112(4):1700-1716. doi: 10.1177/13872877261461161. Epub 2026 Jun 18.

Explainable AI for MRI Alzheimer's disease classification: A comparative analysis

Persson S, Svenberg H, Rial AM, Ferreira D, Moreno R; Alzheimer’s Disease Neuroimaging Initiative.

Neuroimage. 2026 Sep;338:122043. doi: 10.1016/j.neuroimage.2026.122043. Epub 2026 Jun 18.

RNA acetylation modification ac4C: An emerging regulatory hub of RNA metabolism disruption in Alzheimer's disease

Xing L, Liu A, Li J, Jiang K, Li H.

Mol Biol Rep. 2026 Jun 19;53(1):968. doi: 10.1007/s11033-026-12148-4.

A Comprehensive Review on the Microbial Signatures and Metabolic Mechanisms Underlying the Gut-Alzheimer's Disease Axis

Amruthavarshini SN, Kumari N, Anand S.

Mol Neurobiol. 2026 Jun 19;63(1):706. doi: 10.1007/s12035-026-06015-3.

IL-4 in Alzheimer's Disease-Mechanisms and Therapeutic Potential

Liu G, Li W, Chen J, Xu S, Liu X, Wang Z, Yang Q, Xie A, Du Y.

Mol Neurobiol. 2026 Jun 20;63(1):708. doi: 10.1007/s12035-026-06003-7.

Cell-specific MicroRNA networks orchestrate the pathogenesis of Alzheimer's disease

Donepudi K, Eadha S, Rodarte D, Sharma B, Kumar S.

Ageing Res Rev. 2026 Aug;120:103211. doi: 10.1016/j.arr.2026.103211. Epub 2026 Jun 21.

Reprogramming Neuroinflammation: Mitochondrial Targets and Immune Checkpoint Inhibitors in Alzheimer's Disease

Kumar N, Mir PA, Bhutia GT, Chaudhary P, Kaur G, Alam Q, Pawar SD, Gupta SK.

Mol Neurobiol. 2026 Jun 22;63(1):712. doi: 10.1007/s12035-026-05983-w.

Neuroinflammation-centered pathophysiology and therapeutic strategy design in Alzheimer's disease: Cutting-edge developments

Li D, Zhang Z, Lu L, Liu J, Cai W, Hou J, Lu Y, Yu G.

Cell Signal. 2026 Oct;146:112689. doi: 10.1016/j.cellsig.2026.112689. Epub 2026 Jun 26.

From synapses to tangles: PDE inhibitors as therapeutic modulators in Alzheimer's disease

Bagri K, Damde P, Bhatia A, Deshmukh R.

Eur J Pharmacol. 2026 Jul 15;1030:179084. doi: 10.1016/j.ejphar.2026.179084. Epub 2026 Jun 23.

Battling Parkinson's and Alzheimer's: The Neuroprotective Power of Carnosic Acid

Goyal A, Verma A, Kumari A, Mishra MK.

J Biochem Mol Toxicol. 2026 Jul;40(7):e70991. doi: 10.1002/jbt.70991.

Neuroinflammation in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights

Mikołajczak K, Chmiel J, Leszek J.

Cells. 2026 Jun 19;15(12):1111. doi: 10.3390/cells15121111.

The Biological Basis, Mechanisms of Action, and Optimization Strategies of Exosomes Derived from Mesenchymal Stem Cells for the Treatment of Alzheimer's Disease

Zhang C, Long W, Ni J, Chen Z, Wu X, Li M, Du F, Zhao Y, Shen J, Cho CH, He X, Xiao Z.

Mol Neurobiol. 2026 Jun 25;63(1):723. doi: 10.1007/s12035-026-06002-8.

From plastics to pathology: The neurodegenerative impact of Bisphenol-A on Alzheimer's disease

Kumari S, Dhapola R, Sharma P, Paidlewar M, Vellingiri B, Cho SG, Dayem AA, Medhi B, Harikrishnareddy D.

Ageing Res Rev. 2026 Aug;120:103219. doi: 10.1016/j.arr.2026.103219. Epub 2026 Jun 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias